,Response,Share of global prescription drug revenue at risk
0,2026,3.9%
1,2025,3.9%
2,2024,1.7%
3,2023,5.7%
4,2022,3.5%
5,2021,1.2%
6,2020,1.8%
7,2019,5.3%
